Automated cell therapy manufacturer Cellares is implementing layoffs due to the termination of a significant customer partnership. CEO Fabian Gerlinghaus stated the company needs to "resize" following this development. The exact number of affected employees and the identity of the departed customer remain undisclosed. This reduction aims to refocus resources on Cellares' ongoing clinical and commercial programs. The company maintains that its technology is proven and its fundamentals remain strong.
South San Francisco, California
https://www.fiercepharma.com/pharma/cellares-ceo-seeks-resize-company-after-loss-large-cell-therapy-manufacturing-customer